Search

everythinglearnresearchcommunity

for

Search:↓

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Early recognition of methotrexate toxicity symptoms is crucial.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Shaving and applying erythromycin cream and clotrimazole powder effectively treated trichomycosis axillaris.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Platelet-rich fibrin shows promise in healing cartilage and joint injuries but needs more testing.